Forbes April 25, 2024
Walgreens is launching Walgreens Specialty Pharmacy, a $24 billion business that integrates new gene and cell services with existing pharmacy assets including the large specialty pharmacy and home delivery business, AllianceRx.
The move, which takes effect August 1 when AllianceRx Walgreens Pharmacy becomes Walgreens Specialty Pharmacy, comes as Walgreens chief executive Tim Wentworth works to engineer a financial turnaround focusing on providing more healthcare services in stores while beefing up the more lucrative aspects of pharmacy. The creation of Walgreens Specialty Pharmacy should also lay to rest any rumors the company planned to exit the specialty pharmacy business.
“With approximately $24 billion in annual enterprise specialty revenue, Walgreens Specialty Pharmacy is the largest independent provider that offers the industry’s most...
Today's Sponsors
Today's Sponsor